Book NTRK Gene Fusion Test in Saudi Arabia | Lahalak Medical Platform

Discover personalized treatment opportunities through NTRK gene fusion testing. This advanced genetic test identifies tumor responsiveness to modern targeted therapies, ensuring the most effective clinical outcomes for cancer patients.

Scientific name: NTRK Gene Fusion Testing (Pan-Cancer)

A precise genetic test detecting NTRK gene fusions across various tumor types. It identifies candidates for TRK inhibitor therapy, providing effective targeted treatment options regardless of the primary tumor site.

NTRK Gene Fusion Testing (Pan-Cancer) - Targeted Cancer Treatment Guide
Service type Oncology Genetic Testing
Duration 7-14 working days
Fasting Fasting is not required

Included Services

  • Sample collection
  • Genetic sequencing analysis
  • Detailed medical report

Medical Service Information

Purpose of Testing

  • Identify the presence of NTRK gene fusion mutations.
  • Guide clinicians in selecting appropriate TRK inhibitor therapy.
  • Provide treatment options for advanced or refractory tumors.

Who Should Get Tested?

  • Patients with advanced solid tumors.
  • Patients who have not responded to standard treatments.
  • Cases seeking personalized targeted therapy options.

Clinical Significance

  • Helps determine the efficacy of drugs like larotrectinib.
  • A tissue-agnostic test applicable to various cancer types.
  • Minimizes the use of unnecessary systemic chemotherapy.

Conditions & Notices

  • Provision of tumor biopsy or blood sample
  • Provide previous medical reports

Medical services you might also like